Strong vaccine responses during chemotherapy are associated with prolonged cancer survival

Cornelis J. M. Melief*, Marij J. P. Welters, Ignace Vergote, Judith R. Kroep, Gemma G. Kenter, Petronella B. Ottevanger, Wiebren A. A. Tjalma, Hannelore Denys, Mariette I. E. van Poelgeest, Hans W. Nijman, Anna K. L. Reyners, Thierry Velu, Frederic Goffin, Roy Lalisang, Nikki M. Loof, Sanne Boekestijn, Willem Jan Krebber, Leon Hooftman, Sonja Visscher, Brent A. BlumensteinRichard B. Stead, Winald Gerritsen, Sjoerd H. van der Burg*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

27 Citations (Web of Science)
Original languageEnglish
Article number8235
Number of pages12
JournalScience Translational Medicine
Volume12
Issue number535
DOIs
Publication statusPublished - 18 Mar 2020

Keywords

  • REGULATORY T-CELLS
  • CERVICAL-CANCER
  • CLASS-I
  • CISPLATIN
  • E6
  • LEUKOCYTOSIS
  • CARBOPLATIN
  • INDUCTION
  • NIVOLUMAB
  • RECURRENT

Cite this